Granite Point Capital Management’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-184,380
| Closed | -$1.69M | – | 143 |
|
|
2021
Q1 | $1.69M | Sell |
184,380
-362,475
| -66% | -$3.32M | 0.06% | 67 |
|
|
2020
Q4 | $5.55M | Sell |
546,855
-100,000
| -15% | -$1.01M | 0.28% | 14 |
|
|
2020
Q3 | $2.74M | Buy |
646,855
+169,625
| +36% | +$719K | 0.15% | 31 |
|
|
2020
Q2 | $3.31M | Hold |
477,230
| – | – | 0.17% | 26 |
|
|
2020
Q1 | $1.34M | Buy |
477,230
+250,000
| +110% | +$700K | 0.75% | 34 |
|
|
2019
Q4 | $1.1M | Hold |
227,230
| – | – | 0.17% | 38 |
|
|
2019
Q3 | $470K | Sell |
227,230
-2,740
| -1% | -$5.67K | 0.07% | 50 |
|
|
2019
Q2 | $1.14M | Buy |
+229,970
| New | +$1.14M | 0.08% | 36 |
|